In this episode, we celebrate the career of David Whiteman, BM, BCh, FAAP, FACMG, currently a Principal Consultant at Blue Lobster Discovery. With 30 years of experience in academic medicine as a specialist in genetics and metabolics and 20 years of experience in drug development and pharmaceutics, Dr. Whiteman has dedicated his career to the care of patients and treatment of rare diseases, including mitochondrial diseases. Joined part-way through the episode by surprise guest and colleague, Dr. Jerry Vockley, MD, PhD, FACMG of the University of Pittsburgh, UMDF's Philip Yeske, PhD, Dr. Whiteman, and Dr. Vockley discuss the decades of change in rare and mitochondrial medicine, the challenges of rare disease drug development and regulation, and long-awaited developments to come for the mito community.